FDA Vaccine Rules Challenged as Weak at Advisory Panel Meeting

(Bloomberg) -- U.S. vaccine advisers questioned whether safety and efficacy standards set by Food and Drug Administration officials were high enough to warrant emergency authorization of a shot.